The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients
The dysregulation of miRNA expression patterns is one of the many effects developments of cancer, miRNA has been found to express abnormally in hematological neoplasia such as chronic myeloid leukemia and solid malignancies. Resistance and the degree of response following tyrosine kinase inhibitor...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Arabic |
| Published: |
Al-Mustansiriyah University
2023-03-01
|
| Series: | Mustansiriyah Journal of Science |
| Subjects: | |
| Online Access: | https://mjs.uomustansiriyah.edu.iq/index.php/MJS/article/view/1224 |
| _version_ | 1797854274140504064 |
|---|---|
| author | Kawthar Ali Radhi Bassam Francis Matti Israa Hussein Hamzah Rashad Alkasir |
| author_facet | Kawthar Ali Radhi Bassam Francis Matti Israa Hussein Hamzah Rashad Alkasir |
| author_sort | Kawthar Ali Radhi |
| collection | DOAJ |
| description |
The dysregulation of miRNA expression patterns is one of the many effects developments of cancer, miRNA has been found to express abnormally in hematological neoplasia such as chronic myeloid leukemia and solid malignancies. Resistance and the degree of response following tyrosine kinase inhibitor treatment are correlated with miRNA expression. Hence, in this study we tried to study the relationship of miRNA-150 between different breakpoint cluster region–Abelson (BCR- ABL) P210 transcript levels and the role miRNA- 150 between different levels of imatinib optimal response in chronic myeloid leukemia (CML). Our study included sixty chronic myeloid leukemia (CML) patients they were divided into two groups based on response to imatinib therapy, thirty samples of the optimal molecular response of chronic myeloid leukemia (CML) patients, and thirty samples of failure molecular response chronic myeloid leukemia (CML) patients. Thirty samples of apparently healthy volunteers were included and evaluated as control. According to the P210 BCR-ABL%, the results showed a significant difference (P= < 0.0001) between the responder and the failure response CML patients. Assessed the result of miRNA-150 showed a significant difference between both CML patients (P = < 0.0001), assessed miRNA-150 level among different response groups, and failure response of CML patients (P = 0.0002). A cutoff value of response vs. failure response (1.784) with high sensitivity can be a diagnostic value to differentiate between response and failure response. Changing gene expression with different amounts of miRNAs had an impact on drug-gene interactions, with consequences for cell growth and death. Gene expression of different levels miRNA-150 among of CML patients of imatinib therapy showed high expression in response patients than failure response patients. The gene expression level of miRNA-150 differs through different responses in CML patients.
|
| first_indexed | 2024-04-09T20:04:24Z |
| format | Article |
| id | doaj.art-85c217e6e2c0423396969bca6f2f9486 |
| institution | Directory Open Access Journal |
| issn | 1814-635X 2521-3520 |
| language | Arabic |
| last_indexed | 2024-04-09T20:04:24Z |
| publishDate | 2023-03-01 |
| publisher | Al-Mustansiriyah University |
| record_format | Article |
| series | Mustansiriyah Journal of Science |
| spelling | doaj.art-85c217e6e2c0423396969bca6f2f94862023-04-02T11:51:21ZaraAl-Mustansiriyah UniversityMustansiriyah Journal of Science1814-635X2521-35202023-03-0134110.23851/mjs.v34i1.1224The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patientsKawthar Ali Radhi0Bassam Francis Matti1Israa Hussein Hamzah2Rashad Alkasir3Department of Biology, College of Science, Mustansiriyah University, 10052 Baghdad, IRAQ.Consultant Adult Clinical Hematology Department, Baghdad Teaching Hospital, Medical City, 10049 Baghdad, IRAQ,Department of Biology, College of Science, Mustansiriyah University, 10052 Baghdad, IRAQ.Institute of Microbiology and Immunology, Chinese Academy of Science, 100101 Beijing, China The dysregulation of miRNA expression patterns is one of the many effects developments of cancer, miRNA has been found to express abnormally in hematological neoplasia such as chronic myeloid leukemia and solid malignancies. Resistance and the degree of response following tyrosine kinase inhibitor treatment are correlated with miRNA expression. Hence, in this study we tried to study the relationship of miRNA-150 between different breakpoint cluster region–Abelson (BCR- ABL) P210 transcript levels and the role miRNA- 150 between different levels of imatinib optimal response in chronic myeloid leukemia (CML). Our study included sixty chronic myeloid leukemia (CML) patients they were divided into two groups based on response to imatinib therapy, thirty samples of the optimal molecular response of chronic myeloid leukemia (CML) patients, and thirty samples of failure molecular response chronic myeloid leukemia (CML) patients. Thirty samples of apparently healthy volunteers were included and evaluated as control. According to the P210 BCR-ABL%, the results showed a significant difference (P= < 0.0001) between the responder and the failure response CML patients. Assessed the result of miRNA-150 showed a significant difference between both CML patients (P = < 0.0001), assessed miRNA-150 level among different response groups, and failure response of CML patients (P = 0.0002). A cutoff value of response vs. failure response (1.784) with high sensitivity can be a diagnostic value to differentiate between response and failure response. Changing gene expression with different amounts of miRNAs had an impact on drug-gene interactions, with consequences for cell growth and death. Gene expression of different levels miRNA-150 among of CML patients of imatinib therapy showed high expression in response patients than failure response patients. The gene expression level of miRNA-150 differs through different responses in CML patients. https://mjs.uomustansiriyah.edu.iq/index.php/MJS/article/view/1224KEYWORDS: CML, Imatinib mesylate, miRNA, miRNA-150 |
| spellingShingle | Kawthar Ali Radhi Bassam Francis Matti Israa Hussein Hamzah Rashad Alkasir The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients Mustansiriyah Journal of Science KEYWORDS: CML, Imatinib mesylate, miRNA, miRNA-150 |
| title | The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients |
| title_full | The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients |
| title_fullStr | The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients |
| title_full_unstemmed | The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients |
| title_short | The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients |
| title_sort | role of mirna 150 between different bcr abl p210 transcript levels and between different levels of imatinib optimal response in cml patients |
| topic | KEYWORDS: CML, Imatinib mesylate, miRNA, miRNA-150 |
| url | https://mjs.uomustansiriyah.edu.iq/index.php/MJS/article/view/1224 |
| work_keys_str_mv | AT kawtharaliradhi theroleofmirna150betweendifferentbcrablp210transcriptlevelsandbetweendifferentlevelsofimatiniboptimalresponseincmlpatients AT bassamfrancismatti theroleofmirna150betweendifferentbcrablp210transcriptlevelsandbetweendifferentlevelsofimatiniboptimalresponseincmlpatients AT israahusseinhamzah theroleofmirna150betweendifferentbcrablp210transcriptlevelsandbetweendifferentlevelsofimatiniboptimalresponseincmlpatients AT rashadalkasir theroleofmirna150betweendifferentbcrablp210transcriptlevelsandbetweendifferentlevelsofimatiniboptimalresponseincmlpatients AT kawtharaliradhi roleofmirna150betweendifferentbcrablp210transcriptlevelsandbetweendifferentlevelsofimatiniboptimalresponseincmlpatients AT bassamfrancismatti roleofmirna150betweendifferentbcrablp210transcriptlevelsandbetweendifferentlevelsofimatiniboptimalresponseincmlpatients AT israahusseinhamzah roleofmirna150betweendifferentbcrablp210transcriptlevelsandbetweendifferentlevelsofimatiniboptimalresponseincmlpatients AT rashadalkasir roleofmirna150betweendifferentbcrablp210transcriptlevelsandbetweendifferentlevelsofimatiniboptimalresponseincmlpatients |